β-Lactamase-IN-8

β-Lactamase-IN-8

• CAS Number: 1929555-36-1
• UNSPSC Description: β-Lactamase-IN-8 (compound 20) is a potent and oral bioavailable broad-spectrum cyclic boronate β-lactamase inhibitor. β-Lactamase-IN-8 can be used for researching antibacteria[1].
• Target Antigen: Bacterial; Beta-lactamase
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-immunoregulation
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/β-lactamase-in-8.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(N[C@@H](CC=C[C@]1([H])C2)B(O1)OC2=O)CSC
• Molecular Weight: 255.10
• References & Citations: [1]Raja Reddy K, et al. Broad-spectrum cyclic boronate β-lactamase inhibitors featuring an intramolecular prodrug for oral bioavailability. Bioorg Med Chem. 2022;62:116722.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported